Metro Healthcare Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 19.9× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 346.3K). Which is the better fit depends on your goals.
| CARE | RSCH | |
|---|---|---|
Market Cap | 14.23T | 715.5B |
Volume | 346.3K | 30.64M |
Lot | 3.46K | 306.41K |
Turnover | 147.93M | 7.98B |
Average Price | 427.18 | 260.34 |
Value | 147.93M | 7.98B |
Indicative Equilibrium Price | 428 | 256 |
Indicative Equilibrium Volume | 10 | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →